Walleye Capital
MNTA

Walleye Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Walleye Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-75,000
Closed -$3.94M – 1299
2020
Q3 		$3.94M Buy
+75,000
New +$3.1M 0.44% 36

Walleye Capital's MNTA Position: Q4 2020 in Review

Walleye Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 75,000 shares — an estimated $3.94M sold.

Walleye Capital first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $3.94M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Walleye Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Walleye Capital sold 75,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3.94M.
  • Walleye Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Walleye Capital's Momenta Pharmaceuticals, Inc. position peaked at $3.94M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Walleye Capital's 13F filing for Q4 2020, filed 16 Feb 2021.